Royal Philips Launches AI-Enabled Cardiovascular Ultrasound Systems

The system includes FDA-cleared enhancements for 2D and 3D image quality, along with a set of AI-enabled clinical applications. 

Royal Philips has announced the launch of Transcend Plus, featuring upgrades to its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems.

The system includes FDA-cleared enhancements for 2D and 3D image quality, along with a set of AI-enabled clinical applications. 

According to the company, these upgrades enhance sharpness, contrast, and detail in imaging, supporting clearer visualization of cardiac anatomy and function. The improvements aim to increase diagnostic confidence, particularly in complex or technically challenging cases.

A key update is the addition of 2D Auto EF Advanced, which expands AI capabilities for contrast images, an important factor in evaluating cardiac function. The company noted that the integration provides actionable insights to help reduce delays and support timely, evidence-based clinical decisions.

“Building on the momentum of our original Transcend launch, Transcend Plus brings the full power of AI integration to the forefront, giving clinicians the confidence, speed, and precision they need to lead in cardiac care, today and into the future,” said David Handler, business leader of cardiology ultrasound at Philips.

Wider Developments

In July, Royal Philips received FDA 510(k) clearance for its UroNav image-guided navigation system for prostate cancer. The system combines MRI and live ultrasound images for guided biopsies and focal therapy procedures, designed to deliver precise and minimally invasive care. It also offers compatibility with ultrasound devices and needle guides, improved privacy and security tools, and integration with Philips DynaCAD systems.

That same month, the company announced an agreement with Indonesia’s Ministry of Health under the SIHREN project, aimed at expanding access to image-guided therapy systems for heart disease, stroke, and cancer.

Earlier in March, Philips expanded its partnership with Ibex Medical Analytics to support the adoption of AI-enabled digital pathology through the Philips IntelliSite Pathology Solution (PIPS). The company also collaborated with Ingeborg Initiatives to provide expectant parents in Arkansas with access to the Philips Avent Pregnancy+ app, offering personalized information and maternal health resources.

Stay tuned for more such updates on Digital Health News